随着传代次数增加，体细胞杂交系的抗肿瘤免疫原性丧失。
Loss of anti-tumour immunogenicity of a somatic cell hybrid line with increasing subculture.
作者信息
Favre R, Carcassonne Y, Meyer G
出版信息
Br J Cancer. 1975 Jul;32(1):139-41. doi: 10.1038/bjc.1975.140.
Abstract
Good immunoprotection was afforded by A9/SEWA somatic hybrid cells in the C3H mouse/C3H Py tumour system, confirming results previously obtained in the A.SW mouse/SEWA tumour system. However, in this study the immunogenicity decreased with increasing serial subculture of the hybrid line and concomitant chromosome loss.
摘要
在C3H小鼠/C3H Py肿瘤系统中，A9/SEWA体细胞杂交细胞提供了良好的免疫保护作用，这证实了先前在A.SW小鼠/SEWA肿瘤系统中获得的结果。然而，在本研究中，随着杂交系连续传代培养次数的增加以及伴随的染色体丢失，免疫原性降低。
相似文献
1
Loss of anti-tumour immunogenicity of a somatic cell hybrid line with increasing subculture.随着传代次数增加，体细胞杂交系的抗肿瘤免疫原性丧失。
Br J Cancer. 1975 Jul;32(1):139-41. doi: 10.1038/bjc.1975.140.
2
The use of hybrid cells in immunotherapy.
Oncology. 1977;34(2):84-6. doi: 10.1159/000225190.
3
Comparison between different techniques of immuno-protection in the A-SW mouse-SEWA tumour system.A-SW小鼠-SEWA肿瘤系统中不同免疫保护技术的比较。
Br J Cancer. 1974 Apr;29(4):300-4. doi: 10.1038/bjc.1974.70.
4
[Protection afforded by hybrid cells against the inoculation of the parental tumour line (author's transl)].杂交细胞对亲代肿瘤系接种的保护作用（作者译）
Ann Immunol (Paris). 1974 Mar-Apr;125(3):491-7.
5
Interspecies mouse x Akodon urichi somatic cell hybrids: comparative immunogenicity of parental and hybrid cells.
Eur J Cancer (1965). 1976 Jan;12(1):33-9. doi: 10.1016/0014-2964(76)90121-3.
6
Complement-mediated antiserum cytotoxic reactions to human chromosome 7 coded antigen(s): immunoselection of rearranged human chromosome 7 in human-mouse somatic cell hybrids.补体介导的针对人类7号染色体编码抗原的抗血清细胞毒性反应：人-鼠体细胞杂种中重排的人类7号染色体的免疫选择
J Exp Med. 1977 Feb 1;145(2):314-26. doi: 10.1084/jem.145.2.314.
7
Lack of expression of differentiation in mouse teratoma-fibroblast somatic cell hybrids.
Exp Cell Res. 1973 Jan;76(1):191-9. doi: 10.1016/0014-4827(73)90435-7.
8
Immunoprotective capability of somatic hybrid cells in comparison with parental tumor cells maintained in vitro.
Tohoku J Exp Med. 1985 Apr;145(4):447-53. doi: 10.1620/tjem.145.447.
9
[Immune responses to fusion of normal cells and those of tumor-bearing mice].
Nihon Hifuka Gakkai Zasshi. 1978 Nov;88(12):797-802.
本文引用的文献
1
Viral carcinogenesis.病毒致癌作用
Cancer Res. 1961 Sep;21:975-80.
2
Suppression of malignancy by cell fusion.通过细胞融合抑制恶性肿瘤
Nature. 1969 Jul 26;223(5204):363-8. doi: 10.1038/223363a0.
3
Tumor hybrid cells: an immunotherapeutic agent.
J Natl Cancer Inst. 1974 May;52(5):1541-5. doi: 10.1093/jnci/52.5.1541.
4
[Protection afforded by hybrid cells against the inoculation of the parental tumour line (author's transl)].杂交细胞对亲代肿瘤系接种的保护作用（作者译）
Ann Immunol (Paris). 1974 Mar-Apr;125(3):491-7.
5
Expression of polyoma-induced antigens in low malignant hybrids derived from fusion of a polyoma-induced tumour with a fibroblast line.
Nature. 1974 May 3;249(452):47-9. doi: 10.1038/249047a0.
6
[Comparative study of the protective capacity of virus and allogenic, transformed cells in the polyoma virus-mouse system].
C R Acad Hebd Seances Acad Sci D. 1972 Oct 16;275(16):1835-7.
Zotero 插件